Michael L. Kennah
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.
Journal: Transplantation and cellular therapy
Published: August 06, 2026
Using routine asymptomatic Clostridioides difficile testing to identify patients at high risk of developing C. difficile infection during hematopoietic cell transplantation.
Journal: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada
Published: November 28, 2025
Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence From Machine Learning and Regression Models.
Journal: Transplantation and cellular therapy
Published: October 28, 2025
Late Immune Effector Cell-Associated Hematologic Toxicity After CD19 CAR-T Therapy: Incidence, Clinical Course, and Resource Utilization.
Journal: European journal of haematology
Published: October 23, 2025
Factors Associated With Prolonged Inpatient Stay in Patients Undergoing Outpatient Allogeneic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: September 02, 2025
Real-World Selection of Patients for Allogeneic HCT at a Single Centre: Lack of a Suitable Donor and Other Reasons for Not Proceeding.
Journal: Current oncology (Toronto, Ont.)
Published: July 08, 2025
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment.
Journal: British journal of haematology
Published: June 07, 2025
Daratumumab for Posttransplant Autoimmune Hemolytic Anemia.
Journal: European journal of haematology
Published: January 22, 2025
Impact of Day 11 Methotrexate Dose Adjustments due to Mucositis on the Outcomes Following Allogeneic Stem Cell Transplant in the Setting of Anti Thymocyte Globulin (ATG) Based GVHD Prophylaxis.
Journal: European journal of haematology
Published: November 21, 2024
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation.
Journal: Annals of clinical and translational neurology
Published: September 25, 2024
Distance to CAR-T Treatment Center Does Not Impede Delivery.
Journal: European journal of haematology
Published: July 04, 2024
Outcomes with low dose anti-thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation.
Journal: European journal of haematology
Published: May 21, 2024
Last Updated: 09/26/2026